Our knowledge of genomic medicine has increased at an astonishing pace in recent years. As a result of advances in genomics, proteomics and molecular pathology many cancer biomarkers with potential clinical value have been identified. Besides, recent refinements of experimental technique demonstrate that array-based assays, generating huge datasets and finding numerous potentially useful molecules, are becoming widespread. In the present work, artificial neural network (ANN) system is used to simulate a huge database of genes to predict and diagnose the cancer disease. Experimental data collected were tested with artificial neural network technique.
combinational island analysis is probably more accurate in terms of biology, but the datasets can be prohibitive whilst using current statistical methods.
This research work is based on studying epigenetic data for the diagnosis and progression of UCC. The plan is to rank, using a systems-based approach, 12,000 CpG islands/genes according to their association with various clinico-pathological criteria, including tumour behaviour.
